You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
百心安-B(02185.HK)發售價定為每股21.25港元 預計12月23日掛牌上市
格隆匯 12-22 06:42

格隆匯12月22日丨百心安-B(02185.HK)發佈公吿,公司全球發售2393.7萬股股份,其中香港發售股份239.4萬股,國際發售股份2154.3萬股,另有15%超額配股權;發售價已釐定為每股發售股份21.25港元,每手買賣單位500股;華泰國際為獨家保薦人;預期股份將於2021年12月23日於聯交所主板掛牌上市。

根據香港公開發售初步提呈發售的香港發售股份已獲輕微超額認購。合共接獲1994份有效申請,認購合共362.85萬股,相當於根據香港公開發售初步可供認購的H股總數約1.52倍。根據國際發售初步提呈發售的發售股份已獲輕微超額認購,相當於根據國際發售初步可供認購的國際發售股份總數約1.16倍。

根據發售價每股21.25港元計算,公司將自全球發售收取的所得款項淨額估計約為4.417億港元。公司擬將所得款項淨額62.0%用於撥付正在進行的確認性臨牀試驗、註冊備案的籌備事宜以及核心產品Bioheart®的計劃中商業化上市;21.3%用於撥付在中國正在進行的隨機對照臨牀試驗以及腎神經阻斷在研產品第二代Iberis®的持續開發;6.7%用於撥付管線中其他在研產品的研發、進行中臨牀前研究及已規劃的臨牀試驗,包括Bio-Leap®、Bioheart Ultra®、Bioheart®球囊擴張導管、Bioheart®高壓球囊擴張導管及Bioheart®脈衝球囊擴張導管;及10.0%用作一般企業及營運資金用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account